Medicare patients with multiple sclerosis bear the burden of rising drug prices
Over the course of a decade, out-of-pocket costs for multiple sclerosis drugs rose more than sevenfold for Medicare Part D beneficiaries, according to a JAMA Neurology study published today by researchers at the University ...
Aug 26, 2019
0
4